SEC Form 4 · accession 0000899243-15-008138
Marker Therapeutics, Inc. · MRKR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sherry Grisewood
Director
Period of report
Feb 26, 2014
Accepted (ET)
Nov 13, 2015 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001094038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2014 | J | 28,125 | $0.80 | A | 28,330 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents common shares issued by the Company in exchange for cancellation of amounts owed to Ms. Grisewood of $22,500 in connection with the Company's restructuring in early 2014 in which Series A preferred was issued for the debt and subsequently converted into the common stock.